[Dosage of ordinary medication prior to  elective surgery].
Patients will in general benefit from their ordinary medication  in the perioperative phase. However, exceptions and special precautions are  justified with drugs that may have effects, side-effects or interactions,  which are particularly beneficial or harmful during a perioperative  course. This includes drugs with thrombotic or bleeding potential,  antidiabetics, psychopharmaca and some of the drugs used for prophylaxis  and treatment of cardiovascular disease. In such cases individual advice  on dosage should be given.
Avdeling for anestesiologi, Oslo universitetssykehus, Ullevål, Norway. johan.rader@medisin.uio.no
Johan
J
Ræder
Randi
R
Støen
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D001688:Biological Products / Q000008:administration & dosage / Q000009:adverse effects; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D017558:Elective Surgical Procedures / Q000009:adverse effects / Q000592:standards*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006401:Hematologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D059035:Perioperative Period / Q000009:adverse effects / Q000592:standards*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D001688:Biological Products; D002491:Central Nervous System Agents; D005343:Fibrinolytic Agents; D006401:Hematologic Agents; D007004:Hypoglycemic Agents